|
According to experts based in last researches, the usage of antibiotics for acne may increase common illness or diseases, what it was demonstrated by an experiment in which a group of individuals that was treated with antibiotics for acne for more than six weeks (all of hem were volunteers). After the experiment, this group was more than twice as likely to develop an upper respiratory tract infection within one year as individuals with acne who were not treated with antibiotics. The overuse of antibiotics, explain experts, will lead to resistant organisms and an increase in infectious illness. There have been, however, few studies about people who have actually been exposed to antibiotics for long periods and there the importance of this one. According to experts, the ideal people to study consequences of using antibiotics for acne are patients with acne (an inflammatory disease involving the sebaceous glands of the skin; characterized by papules or pustules or comedones) , who use for long-term antibiotic therapy, representing a unique and natural population in which to study the effects of long-term antibiotic use. A group of experts from the School of Medicine of the University of Pennsylvania, Philadelphia, identified individuals diagnosed with acne between the years 1987 and 2002, aged 15 to 35 years, in a medical database in the United Kingdom (UK). The researchers searched information such as how often individuals were likely to see a physician, and compared the incidence of a common infectious illness, upper respiratory tract infection (URTI), in individuals treated with antibiotics for acne and those whose acne was not treated with these medications. Experts reported that "within the first year of observation, 15.4 per cent of the patients with acne had at least one URTI, and within that year, the odds of a URTI developing among those receiving antibiotic treatment were 2.15 times greater than among those who were not receiving antibiotic treatment". Acne: Rambazole Can Be A Good Medication Against Acne In Future A study with Rambazole, a novel retinoic acid metabolism-blocking agent (RAMBA), determined that 94 per cent of subjects -with moderate-to-severe acne treated with 1 mg of oral Rambazole once daily for 12 consecutive weeks- experienced reduction in total acne lesion count of more than 50 per cent and 35 per cent were considered "cleared or almost cleared. This study points to the production of this medication on future, since Barrier Therapeutics, Inc. reported positive Phase 2a data for its oral formulation of Rambazole (TM) in the treatment of moderate to severe acne and positive biological activity data for its topical formulation of this product. Experts explain that a subject must have had more than 90 per cent reduction in total lesion count to be considered "cleared or almost cleared". According to their report, inflammatory and non-inflammatory lesions responded equally well to treatment. There were no serious effects related to the treatment with this new component. Only some patients of the group in study experienced dryness of skin and lips as non-serious side effects. Geert Cauwenbergh, Ph.D., Chairman and Chief Executive Officer of Barrier Therapeutics, Inc. explained that "these positive Phase 2a results indicate that oral Rambazole is active in moderate to severe inflammatory acne, and that depending on the outcome of future, full scale clinical trials, this drug may one day fill the need for safe and effective oral treatments for moderate and severe acne. These results further build on our previously announced promising clinical data for oral Rambazole for psoriasis". Did You Know That the First Step to Living Acne Free Is Understanding It's Underlying Causes? Best Acne products Clear Skin Max Review Sven Hyltén-Cavallius
Related Articles -
acne treatments tips, nbspacne treatments, acne solution products, acne solution,
| 
